Federal regulators may soon settle a years-long debate over cheaper, over-the-counter hearing aids — an issue that has divided Minnesota companies with a stake in the industry.
On one side are the disruptors: medical technology firms that want to do for hearing aids what Warby Parker did for eyeglasses. On the other side are the industry veterans: established hearing aid companies that worry lax regulation could hurt consumers by not ensuring proper care and diagnosis.
More than 38 million Americans — or 15% of adults — report having some trouble hearing.
Standard hearing aids are typically expensive and not covered by health insurance. These steep costs have prevented many people who could benefit from getting hearing aids. A 2017 survey from the Hearing Health Foundation found that only 14% of Americans with hearing loss use hearing aids.
Over-the-counter (OTC) hearing aids won't require a prescription and could be available on retail store shelves and online before the end of the year.
In 2017, Congress directed the U.S. Food and Drug Administration to create a category and regulatory structure for OTC hearing aids within three years, but the process has met several delays. The Biden administration tried to jumpstart it by including OTC hearing aids as part of a sweeping executive order in July 2021 encouraging increased competition across a host of U.S. industries.
OTC hearing aids are intended for adults with mild to moderate hearing loss, not for people with more severe hearing problems.
Dr. Melisa Oblander, director of audiology for M Health Fairview, supports the concept of OTC hearing aids.